BostonGene-Integrated Genomic Registry (BIGR)

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
BostonGene
Study ID
NCT04991922
Status
Recruiting
Apply to this trial

Conditions

  • Malignancy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types

Key Dates

Start date
Jul 1, 2021
Status verified
Feb 2024
Primary completion
Jul 1, 2031
Completion
Jul 1, 2036

Study Design

Enrollment
100,000 participants (estimated)

Primary Outcome Measure

association between major finding and outcome, Descriptive [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
BostonGeneWalthamMassachusetts02453
Krystle Nomie, PhD
[email protected]
617-658-4545

Find similar trials in Waltham, MA

By research site
BostonGene· Waltham, MA

Related Studies